Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Moisseiev

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
American Journal of Ophthalmology Case Reports|May 22, 2018
Benign yellow dot maculopathyElad Moisseiev
Eye (London, England)|November 28, 2019
Initial treatment of macular oedema due to central retinal vein occlusion-which anti-VEGF agent to choose?Elad Moisseiev, Anat Loewenstein
Clinical Ophthalmology (Auckland, N.Z.)|October 16, 2020
The Top 100 Most-Cited Papers on Intravitreal Injections: A Bibliographic PerspectiveEytan Nov, Elad Moisseiev
Developments in Ophthalmology|April 21, 2017
Diabetic Macular Edema: Emerging Strategies and Treatment AlgorithmsElad Moisseiev, Anat Loewenstein
Harefuah|May 12, 2024
[LOWER EYELID BLEPHAROPLASTY]Elad Moisseiev, Anat Loewenstein
Harefuah|May 12, 2024
[OPHTHALMOLOGY - ON THE TIP OF THE SPEAR]Elad Moisseiev, Anat Loewenstein
Developments in Ophthalmology|March 29, 2017
Drug Delivery to the Posterior Segment of the EyeElad Moisseiev, Anat Loewenstein
Lancet (London, England)|November 8, 2016
Retinal detachment in severe myopiaElad Moisseiev, Glenn Yiu
Eye (London, England)|September 1, 2019
How to manage patients with center-involving diabetic macular edema and good visual acuity? An answer to a common clinical questionElad Moisseiev, Anat Loewenstein
Eye (London, England)|September 21, 2019
Abicipar pegol-a novel anti-VEGF therapy with a long duration of actionElad Moisseiev, Anat Loewenstein
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
American Journal of Ophthalmology Case Reports|May 22, 2018
Benign yellow dot maculopathyElad Moisseiev
Eye (London, England)|November 28, 2019
Initial treatment of macular oedema due to central retinal vein occlusion-which anti-VEGF agent to choose?Elad Moisseiev, Anat Loewenstein
Clinical Ophthalmology (Auckland, N.Z.)|October 16, 2020
The Top 100 Most-Cited Papers on Intravitreal Injections: A Bibliographic PerspectiveEytan Nov, Elad Moisseiev
Developments in Ophthalmology|April 21, 2017
Diabetic Macular Edema: Emerging Strategies and Treatment AlgorithmsElad Moisseiev, Anat Loewenstein
Harefuah|May 12, 2024
[LOWER EYELID BLEPHAROPLASTY]Elad Moisseiev, Anat Loewenstein
Harefuah|May 12, 2024
[OPHTHALMOLOGY - ON THE TIP OF THE SPEAR]Elad Moisseiev, Anat Loewenstein
Developments in Ophthalmology|March 29, 2017
Drug Delivery to the Posterior Segment of the EyeElad Moisseiev, Anat Loewenstein
Lancet (London, England)|November 8, 2016
Retinal detachment in severe myopiaElad Moisseiev, Glenn Yiu
Eye (London, England)|September 1, 2019
How to manage patients with center-involving diabetic macular edema and good visual acuity? An answer to a common clinical questionElad Moisseiev, Anat Loewenstein
Eye (London, England)|September 21, 2019
Abicipar pegol-a novel anti-VEGF therapy with a long duration of actionElad Moisseiev, Anat Loewenstein
Pageof 13